• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MassDevice On Call: Study shows many women skip mammograms

MassDevice On Call: Study shows many women skip mammograms

December 13, 2010 By MassDevice staff

MassDevice On Call

Study shows many women skip mammograms. Despite the uproar over mammography guideline changes, many women still skip screenings, according to a Medco Health Solutions study of utilization in more than 1.5 million women, reports MedPage Today.

Wikileaks-released cable shows Pfizer hired investigators to pressure Nigeria to drop lawsuit. Pfizer (NYSE:PFE) hired investigators to dig up dirt on Nigeria’s then-attorney general early last year to pressure him to drop a $6 billion lawsuit over a 1996 drug experiment on ill children, according to a classified U.S. diplomatic cable, reports The Washington Post.

Scientists prod sperm-producing cells into making insulin. Researchers at the Georgetown University Medical Center have been able to coax human cells that normally produce sperm to make insulin instead. After the cells were transplanted, they briefly cured mice with type 1 diabetes, reports Bloomberg Businessweek.

Sanofi extends deadline for Genzyme takeover. Sanofi-Aventis SA (NYSE:SNY) moved the deadline back for its tender offer to take over Genzyme (NSDQ:GENZ) to Jan. 21, reports Bloomberg.

Reimbursement rates not equal. Unequal access to healthcare is hardly a new phenomenon in the United States, but the country is moving toward rationing at an unprecedented pace. The underlying problem is that doctors are reimbursed at different rates, reports The New York Times.

Prodded by activists. The FDA is reviewing the evidence used to declare that the amount of mercury in dental amalgam is “not high enough to cause harm” to patients, according to The Los Angeles Times.

Pfizer ends Thelin studies. Pfizer has ended worldwide clinical trials of blood pressure medicine Thelin, pulling the drug off shelves in the European Union, Australia and Canada because the drug poses a serious liver damage risk.

Pittsburgh angel fund looks for more money. Pittsburgh Equity Partners, an angel fund formed four years ago to fund early stage companies in western Pennsylvania, has retained Trustmont Financial Group to help it raise as much as $50 million through a private offering, reports the Pittsburgh Business Times.

Healthcare reform law oops. Drug companies Genentech and Allergan are discontinuing orphan drug discounts for children’s hospitals, an unintended consequence of the Patient Protection and Affordable Care Act, according to The New York Times.

Material from MedCity News was used in this report.

Filed Under: Business/Financial News, Healthcare Reform, News Well Tagged With: Genzyme Corp., Pfizer

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy